| Krystyna L Abdulla, DO | |
|
14555 W National Ave, New Berlin, WI 53151-4494 | |
| (262) 827-3636 | |
| Not Available |
| Full Name | Krystyna L Abdulla |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 14555 W National Ave, New Berlin, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205146578 | NPI | - | NPPES |
| 100051839 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 64181 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waukesha Memorial Hospital | Waukesha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Medical Group Inc | 3476465188 | 417 |
News Archive
An international group of researchers report success in mice of a method of using positron emission tomography scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
A new viewpoint article published in the journal JAMA Internal Medicine dissects different factors that contributed to the dire COVID-19 situation in Italy, emphasizing several aspects relevant to the international healthcare community.
University of Georgia researchers have developed a simple technique to measure an individual's visual processing speed-the speed at which an individual can comprehend visual information-in order to identify whether or not they may have cognitive issues.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell non-Hodgkin's lymphoma (NHL).
› Verified 1 days ago
| Entity Name | Prohealth Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
An international group of researchers report success in mice of a method of using positron emission tomography scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
A new viewpoint article published in the journal JAMA Internal Medicine dissects different factors that contributed to the dire COVID-19 situation in Italy, emphasizing several aspects relevant to the international healthcare community.
University of Georgia researchers have developed a simple technique to measure an individual's visual processing speed-the speed at which an individual can comprehend visual information-in order to identify whether or not they may have cognitive issues.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell non-Hodgkin's lymphoma (NHL).
› Verified 1 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031113000164 |
News Archive
An international group of researchers report success in mice of a method of using positron emission tomography scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
A new viewpoint article published in the journal JAMA Internal Medicine dissects different factors that contributed to the dire COVID-19 situation in Italy, emphasizing several aspects relevant to the international healthcare community.
University of Georgia researchers have developed a simple technique to measure an individual's visual processing speed-the speed at which an individual can comprehend visual information-in order to identify whether or not they may have cognitive issues.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell non-Hodgkin's lymphoma (NHL).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Krystyna L Abdulla, DO 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 389-2377 | Krystyna L Abdulla, DO 14555 W National Ave, New Berlin, WI 53151-4494 Ph: (262) 827-3636 |
News Archive
An international group of researchers report success in mice of a method of using positron emission tomography scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.
A new viewpoint article published in the journal JAMA Internal Medicine dissects different factors that contributed to the dire COVID-19 situation in Italy, emphasizing several aspects relevant to the international healthcare community.
University of Georgia researchers have developed a simple technique to measure an individual's visual processing speed-the speed at which an individual can comprehend visual information-in order to identify whether or not they may have cognitive issues.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of favorable clinical data for SAR3419 in the treatment of B-cell non-Hodgkin's lymphoma (NHL).
› Verified 1 days ago
Enrique W Luy, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6165 Preston Ln, New Berlin, WI 53151 Phone: 414-525-0221 | |
Dr. Peter G. Parrino, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4805 S Moorland Rd, New Berlin, WI 53151 Phone: 262-798-7200 Fax: 262-798-7201 |